Cleared Traditional

K855071 - IMIPENEM SUSCEPTIBILITY POWDER
(FDA 510(k) Clearance)

Mar 1986
Decision
77d
Days
Class 2
Risk

K855071 is an FDA 510(k) clearance for the IMIPENEM SUSCEPTIBILITY POWDER. This device is classified as a Susceptibility Test Powders, Antimicrobial (Class II - Special Controls, product code JTT).

Submitted by Merck, Sharp & Dohme (West Point, US). The FDA issued a Cleared decision on March 6, 1986, 77 days after receiving the submission on December 19, 1985.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1640.

Submission Details

510(k) Number K855071 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 1985
Decision Date March 06, 1986
Days to Decision 77 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code JTT — Susceptibility Test Powders, Antimicrobial
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1640

Similar Devices — JTT Susceptibility Test Powders, Antimicrobial

All 13
SENSITITRE 18-24 HOUR SUSCEPTIBILITY PLATES WITH SPARFLOXACIN
K983310 · Accumed Intl., Inc. · Dec 1998
PASCO MIC AND MIC/ID PANELS
K935805 · Pasco Laboratories, Inc. · Jun 1994
BACTEC PYRAZINAMIDE SUSCEPTIBILITY TEST
K895362 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Dec 1989
MODIFIED IMIPENEM SUSCEPTIBILITY POWDER
K880574 · Merck, Sharp & Dohme · May 1988
CIPRO (TM) DIAGNOSTIC POWDER
K872081 · Miles Pharmaceuticals · Jun 1987
NORFLOXACIN SUSCEPTIBILITY POWDER
K864442 · Merck, Sharp & Dohme · Dec 1986